type A (NPD A), the acute infantile form; type B (NPD-B), a less common, chronic, non-neurological form; and type C (NPD-C), a biochemically and genetically distinct form of the disease.
Ultimately, the nervous system becomes severely damaged and patients with Types C and D Niemann-Pick disease die.
A diagnosis of Niemann-Pick disease is confirmed by analyzing a sample of tissue.
The different types seem to be related to the activity level of the enzyme sphingomyelinase.
At least five different forms of Niemann-Pick disease (NPD) have been identified.
Types C or D NPD are related to cholesterol transfer out of cells.
Both Niemann-Pick disease types A and B occur in many ethnic groups; however, they occur more frequently among individuals of Ashkenazi Jewish descent than in the general population.
Some adults with Niemann-Pick disease (Type E) may also show a loss of muscle coordination.
Low-cholesterol diets may be helpful for patients with Types C and D.
In patients with Types A and B NPD, there is a build up of sphingomyelin in cells of the brain, liver, spleen, kidney and lung.
Prenatal diagnosis of Types A and B of NPD can be done with amniocentesis or chorionic villus sampling.
A carrier for Niemann-Pick disease typically has a heterozygous genotype, meaning they possess one normal allele and one mutated allele for the NPC1 or NPC2 gene, depending on the specific type of Niemann-Pick disease. This genotype can be represented as "N/n," where "N" denotes the normal allele and "n" the mutated allele. Carriers usually do not exhibit symptoms of the disease but can pass the mutated allele to their offspring.
Children with Types C or D grow normally in early childhood, but eventually develop difficulty in walking and loss of muscle coordination.